




Searching News Database: Angiox
HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
HSMN NewsFeed - 13 May 2009
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
HSMN NewsFeed - 4 Feb 2008
Steven Steinhubl, MD, Joins The Medicines Company as Global Vice President, Thrombosis
Steven Steinhubl, MD, Joins The Medicines Company as Global Vice President, Thrombosis
HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
Additional items found! 3

Members Archive contains
3 additional stories matching:
Angiox
(Password required)
Angiox
(Password required)